Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We observed previously that combined small interfering RNAs (siRNAs) targeting CrkII and CrkL, known activators of guanine nucleotide exchange factor DOCK1, strongly inhibit Caco-2 intestinal epithelial cell spreading and migration on collagen IV. DOCK1 siRNA reduced its expression >95% in Caco-2 cells but inhibited spreading much less than combined CrkII/CrkL siRNAs, suggesting that CrkII/CrkL interact with additional DOCK proteins. siRNA targeting
DOCK5
, a closely related DOCK1 family member, inhibited Caco-2 spreading similarly to DOCK1 siRNA, and the combined siRNAs synergistically inhibited spreading. Similar results were observed in human umbilical vein endothelial cells, and
reverse transcriptase
PCR demonstrated
DOCK5
siRNA reduction of
DOCK5
expression in both cell types. Combined DOCK1/
DOCK5
siRNAs also inhibited Caco-2 migration and lamellipodial extension. Expression of
DOCK5
cDNA, with silent mutations in the siRNA target region allowing expression simultaneously with
DOCK5
siRNA, required CrkII/CrkL to restore cell spreading and
DOCK5
coimmunoprecipitated with CrkII and CrkL.
DOCK5
association with CrkII and CrkL was greatly reduced by mutations in their NH2-terminal SH3 domains. Expression of the
DOCK5
COOH-terminal region (Met1738-Gln1870), containing potential Src homology 3 domain-binding proline-rich sites but lacking other functional regions, inhibited Caco-2 spreading and coimmunoprecipitated with CrkL. Coimmunoprecipitation of full-length
DOCK5
with CrkL was strongly reduced by deletion of
DOCK5
COOH-terminal amino acids 1832-1870. Green fluorescent protein-tagged
DOCK5
localized to the membrane of Caco-2 cells spreading on collagen IV. In these studies, we describe human
DOCK5
cloning and expression, our results indicating that, along with DOCK1,
DOCK5
is an important mediator of CrkII/CrkL regulation of Caco-2 spreading and migration on collagen IV.
...
PMID:DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. 1900 29